MALVIRUS: an integrated application for viral variant analysis.

Simone CiccolellaLuca DentiPaola BonizzoniGianluca Della VedovaYuri PirolaMarco Previtali

Published in: BMC bioinformatics (2022)

Tests on Illumina and Nanopore samples proved the efficiency and the effectiveness of MALVIRUS in analyzing SARS-CoV-2 strain samples with respect to publicly available data provided by NCBI and the more complete dataset provided by GISAID. A comparison with state-of-the-art tools showed that MALVIRUS is always more precise and often have a better recall.

Keyphrases

sars cov
randomized controlled trial
respiratory syndrome coronavirus
systematic review
electronic health record
single molecule
big data
deep learning